SecBot SecBot
SC 13G ·Filed Nov 10, 2026

RGNX

REGENXBIO Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6d 18h ago SEC0000093751-26-000715
Passive investor 5%+ stake
Actionable Insight • Neutral

State Street's passive stake at 4.8% is just below the 5% threshold, suggesting routine index or custody holdings rather than a high-conviction bet. Monitor upcoming 13F filings for any material position changes, and watch for the Q4 2026 sura-vec pivotal data in wet AMD as a potential catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$7.69
T+0 close · Nov 10, 2026 · via day close
Latest settled
+10.14%
T+1 · $8.47
Vs SPY
+8.82%
α at T+1
Next horizon
T+5
in 3h
  1. T+0 · Nov 10 $7.69entry
  2. T+1 · 6d ago +10.14%α +8.82% · $8.47
  3. T+4 · todayOpen
  4. T+5 · in 3h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corp. filed a new SC 13G disclosing a 4.8% passive stake in REGENXBIO Inc., confirming the position is held in the ordinary course of business with no intent to influence control. The filing follows a prior 13G from JPMorgan Chase (5.3%) and comes five days after REGENXBIO reported Q3 revenue of $9.2M (down 69% YoY) and a narrower-than-expected GAAP net loss of $0.62 per share.

Key Financial Metrics

Stake
4.8%
Investor
STATE STREET CORP

Key Facts

  • State Street Corp. filed a new SC 13G disclosing beneficial ownership of 3,153,366 shares of REGENXBIO common stock.
  • The stake represents 4.8% of shares outstanding as of September 30, 2026.
  • State Street certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
  • This is a new filing from State Street, not an amendment; a prior State Street SC 13G was filed on May 12, 2026.
  • The filing follows a JPMorgan Chase SC 13G on October 13, 2026 disclosing a 5.3% passive stake.

Financial Impact

4.8% passive stake valued at approximately $24M based on $504M market cap

ownership

Risk Factors

  • Passive 13G filing with no activist intent; no immediate catalyst from this disclosure alone.
  • Revenue declined 69% YoY in Q3 2026 due to ZOLGENSMA patent expiration, creating fundamental headwinds.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000715
Document: 0000093751-26-000715-index.html0000093751-26-000715
Document: 0000093751-26-000715.txt0000093751-26-000715

Track record

15 reports on RGNX

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +29.65% at T+60 after the Jul 20, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $7.69 Now $7.32 −4.81% settles Feb 8
  2. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.38 Now $7.32 +0.81% settles Feb 3
  3. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $7.71 Now $7.32 −5.06% settles Feb 2
  4. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $6.93 Now $7.32 +5.70% settles Jan 13
  5. Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $7.26 Now $7.32 +0.83% settles Jan 8
  6. Aug 27, 202611w ago Insider Buy Bullish 5/10 Entry $9.66 Now $7.32 −24.22% settles Nov 23
  7. Aug 25, 202611w ago 8-K Neutral 3/10 Entry $9.38 Now $7.32 −21.96% settles Nov 19
  8. Aug 6, 202614w ago 8-K Bullish 7/10 Entry $11.28 to $7.41 Now $7.32 −35.11% ▼ −34.31% −32.88% vs SPY
  9. Aug 3, 202615w ago Press Release Neutral 1/10 Entry $9.96 to $6.59 Now $7.32 −26.51% ▼ −33.84% −35.62% vs SPY
  10. Jul 20, 202617w ago 8-K Bearish 6/10 Entry $10.32 to $7.26 Now $7.32 +29.07% ▲ +29.65% +34.49% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 5h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026